Pra Health (PRAH)
DT Midstream Set to Join S&P MidCap 400
Veradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research Network
Here's Why You Should Retain PRA Health (PRAH) Stock for Now
Investors continue to be optimistic about PRA Health (PRAH) owing to its strategic alliances and solid CRO market prospects.
PRA Health Sciences Larger Than S&P 500 Component F5 Networks
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component PRA Health Sciences Inc (PRAH) was identified as having a larger market cap than the smaller end of the S&P 500, for example F5 Networks, Inc. (FFIV), according to The Online Investor..
Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors
Avantor Stock Showing Improved Relative Strength After 350%-Plus Run In Little More Than A Year
In terms of fundamentals, Avantor posted 106% EPS growth last quarter, to 35 cents a share. In the three preceding quarters its EPS grew 19%, 60% and 53%.
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.
Pioneros de PRA Health Sciences conectan pacientes de ensayos clínicos con sus datos del mundo real con Synoma
Los patrocinadores de investigaciones farmacéuticas, biotecnológicas y de otro tipo ahora pueden conectar sus estudios clínicos con datos longitudinales del mundo real, lo que acelera el desarrollo de fármacos y alineamiento con la Ley de Curas del Siglo XXI
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.
Pioneros de PRA Health Sciences conectan pacientes de ensayos clínicos con sus datos del mundo real con Synoma
Los patrocinadores de investigaciones farmacéuticas, biotecnológicas y de otro tipo ahora pueden conectar sus estudios clínicos con datos longitudinales del mundo real, lo que acelera el desarrollo de fármacos y alineamiento con la Ley de Curas del Siglo XXI
First Week of May 21st Options Trading For PRA Health Sciences (PRAH)
Investors in PRA Health Sciences Inc (PRAH) saw new options begin trading this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PRAH options chain for the new May 21st contracts and identified the following put contract of particular interest.
First Week of PRAH June 18th Options Trading
Investors in PRA Health Sciences Inc (PRAH) saw new options begin trading this week, for the June 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PRAH options chain for the new June 18th contracts and identified the following put contract of particular interest.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - PRAH, TPCO, MDCA, AEGN, WIFI
PRA Health Sciences (PRAH) Q1 Earnings and Revenues Beat Estimates
PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 0.75% and 9.22%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?